Structural biology of the p53 tumour suppressor

Current Opinion in Structural Biology

Volumn 19, Issue 2, 2009, Pages 197-202

  Okorokov, Andrei L ^a   Orlova, Elena V ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CYTOLOGY; DNA BINDING; ELECTRON MICROSCOPY; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; BASE SEQUENCE; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 64549105630     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2009.02.003     Document Type: Review

References (56)

1. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 6810 (2000) 307-310
2. Appella E., and Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268 10 (2001) 2764-2772
3. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 10 4 (2003) 431-442
4. Murray-Zmijewski F., Slee E.A., and Lu X. A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 9 9 (2008) 702-712
5. Janus F., Albrechtsen N., Dornreiter I., Wiesmuller L., Grosse F., and Deppert W. The dual role model for p53 in maintaining genomic integrity. Cell Mol Life Sci 55 1 (1999) 12-27
6. Sengupta S., and Harris C.C. p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6 1 (2005) 44-55
7. Friedman P.N., Chen X., Bargonetti J., and Prives C. The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc Natl Acad Sci U S A 90 8 (1993) 3319-3323
8. Wang P., Reed M., Wang Y., Mayr G., Stenger J.E., Anderson M.E., Schwedes J.F., and Tegtmeyer P. p53 domains: structure, oligomerization, and transformation. Mol Cell Biol 14 8 (1994) 5182-5191
9. Milner J., and Medcalf E.A. Co-translation of mutant p53 with wild type drives the wild-type p53 into the mutant conformation. Cell 65 (1991) 765-774
10. Hupp T.R., and Lane D.P. Allosteric activation of latent p53 tetramers. Curr Biol 4 10 (1994) 865-875
11. Veprintsev D.B., Freund S.M., Andreeva A., Rutledge S.E., Tidow H., Cañadillas J.M., Blair C.M., and Fersht A.R. Core domain interactions in full-length p53 in solution. Proc Natl Acad Sci U S A 103 7 (2006) 2115-2119. NMR studies of full length human p53 with four stabilising mutations in the core domain. This paper describes interactions between core domains for free p53 and in complex with DNA.
12. Bargonetti J., Manfredi J.J., Chen X., Marshak D.R., and Prives C. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev 7 12B (1993) 2565-2574
13. Pavletich N.P., Chambers K.A., and Pabo C.O. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 7 12B (1993) 2556-2564
14. el-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., and Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1 1 (1992) 45-49
15. Funk W.D., Pak D.T., Karas R.H., Wright W.E., and Shay J.W. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 12 6 (1992) 2866-2871
16. Tokino T., Thiagalingam S., el-Deiry W.S., Waldman T., Kinzler K.W., and Vogelstein B. p53 tagged sites from human genomic DNA. Hum Mol Genet 3 9 (1994) 1537-1542
17. Halazonetis T.D., and Kandil A.N. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J 12 13 (1993) 5057-5064
18. Ahn J., and Prives C. The C-terminus of p53: the more you learn the less you know. Nat Struct Biol 8 9 (2001) 730-732
19. Yakovleva T., Pramanik A., Terenius L., Ekstrom T.J., and Bakalkin G. p53 latency-out of the blind alley. Trends Biochem Sci 27 12 (2002) 612-618
20. Dawson R., Müller L., Dehner A., Klein C., Kessler H., and Buchner J. The N-terminal domain of p53 is natively unfolded. J Mol Biol 332 5 (2003) 1131-1141
21. Chang J., Kim D.H., Lee S.W., Choi K.Y., and Sung Y.C. Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein. J Biol Chem 270 42 (1995) 25014-25019
22. Walker K.K., and Levine A.J. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci U S A 93 26 (1996) 15335-15340
23. Kussie P.H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A.J., and Pavletich N.P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274 5289 (1996) 948-953
24. Bochkareva E., Kaustov L., Ayed A., Yi G.S., Lu Y., Pineda-Lucena A., Liao J.C., Okorokov A.L., Milner J., Arrowsmith C.H., and Bochkarev A. Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A. Proc Natl Acad Sci U S A 102 (2005) 15412-15417. X-ray crystallography and NMR studies of the p53 N-terminal domain in complex with RPA suggest a novel mechanism for protein-protein interaction based on DNA mimicry.
25. Cain C., Miller S., Ahn J., and Prives C. The N terminus of p53 regulates its dissociation from DNA. J Biol Chem 275 51 (2000) 39944-39953
26. Cho Y., Gorina S., Jeffrey P.D., and Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265 5170 (1994) 346-355
27. Gorina S., and Pavletich N.P. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274 5289 (1996) 1001-1005
28. Zhao K., Chai X., Johnston K., Clements A., and Marmorstein R. Crystal structure of the mouse p53 core DNA-binding domain at 2, 7 A resolution. J Biol Chem 276 15 (2001) 12107-12120
29. Derbyshire D.J., Basu B.P., Serpell L.C., Joo W.S., Date T., Iwabuchi K., and Doherty A.J. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J 21 14 (2002) 3863-3872
30. Joo W.S., Jeffrey P.D., Cantor S.B., Finnin M.S., Livingston D.M., and Pavletich N.P. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev 16 5 (2002) 583-593
31. Huyen Y., Jeffrey P.D., Derry W.B., Rothman J.H., Pavletich N.P., Stavridi E.S., and Halazonetis T.D. Structural differences in the DNA binding domains of human p53 and its C. elegans ortholog Cep-1. Structure 12 7 (2004) 1237-1243
32. Ho W.C., Fitzgerald M.X., and Marmorstein R. Structure of the p53 Core Domain Dimer Bound to DNA. J Biol Chem 281 (2006) 20494-20502
33. Joerger A.C., and Fersht A.R. Structural biology of the tumor suppressor p53. Annu Rev Biochem 77 (2008) 557-582. A wide-ranging review on structural biology of p53 that brings together biophysical and biochemical data obtained during the past decade.
34. Jeffrey P.D., Gorina S., and Pavletich N.P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1, 7 angstroms. Science 267 5203 (1995) 1498-1502
35. Clore G.M., Ernst J., Clubb R., Omichinski J.G., Kennedy W.M., Sakaguchi K., Appella E., and Gronenborn A.M. Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol 2 4 (1995) 321-333
36. Iwabuchi K., Li B., Bartel P., and Fields S. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization. Oncogene 8 6 (1993) 1693-1696
37. Mujtaba S., He Y., Zeng L., Yan S., Plotnikova O., Sachchidanand, Sanchez R., Zeleznik-Le N.J., Ronai Z., and Zhou M.M. Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell 13 (2004) 251-263
38. Avalos J.L., Celic I., Muhammad S., Cosgrove M.S., Boeke J.D., and Wolberger C. Structure of a Sir2 enzyme bound to an acetylated p53 peptide. Mol Cell 10 3 (2002) 523-535
39. Rustandi R.R., Baldisseri D.M., and Weber D.J. Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat Struct Biol 7 (2000) 570-574
40. Kitayner M., Rozenberg H., Kessler N., Rabinovich D., Shaulov L., Haran T.E., and Shakked Z. Structural basis of DNA recognition by p53 tetramers. Mol Cell 22 (2006) 741-753. Several crystal structures of the p53 core domain in complex with different specific DNA targets. The paper extends previous studies and provides a detailed analysis of the p53-DNA interaction.
41. Okorokov A.L., Sherman M.B., Plisson C., Grinkevich V., Sigmundsson K., Selivanova G., Milner J., and Orlova E.V. The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity. EMBO J 25 21 (2006) 5191-5200. The first structural analysis of the full length murine p53 protein using cryo-EM and single particle analysis. The results suggest a new model for organisation of the p53 tetramer.
42. Tidow H., Melero R., Mylonas E., Freund S.M., Grossmann J.G., Carazo J.M., Svergun D.I., Valle M., and Fersht A.R. Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc Natl Acad Sci U S A 104 30 (2007) 12324-12329. Structural analysis of the full length stabilised human p53 protein using a combination of NMR spectroscopy, negative stain electron microscopy and SAXS analysis.
43. Hansen S., Lane D.P., and Midgley C.A. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability. J Mol Biol 275 4 (1998) 575-588
44. Muller-Tiemann B.F., Halazonetis T.D., and Elting J.J. Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. Proc Natl Acad Sci U S A 95 11 (1998) 6079-6084
45. Hupp T.R., Meek D.W., Midgley C.A., and Lane D.P. Regulation of the specific DNA binding function of p53. Cell 71 5 (1992) 875-886
46. Horikoshi N., Usheva A., Chen J., Levine A.J., Weinmann R., and Shenk T. Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol Cell Biol 15 1 (1995) 227-234
47. Lin Y.L., Chen C., Keshav K.F., Winchester E., and Dutta A. Dissection of functional domains of the human DNA replication protein complex replication protein A. J Biol Chem 271 29 (1996) 17190-17198
48. Malecka K.A., Ho W.C., and Marmorstein R. Crystal structure of a p53 core tetramer bound to DNA. Oncogene (2008 November 3) [Epub ahead of print]
49. Stenger J.E., Tegtmeyer P., Mayr G.A., Reed M., Wang Y., Wang P., Hough P.V., and Mastrangelo I.A. p53 oligomerization and DNA looping are linked with transcriptional activation. EMBO J 13 24 (1994) 6011-6020
50. Jackson P., Mastrangelo I., Reed M., Tegtmeyer P., Yardley G., and Barrett J. Synergistic transcriptional activation of the MCK promoter by p53: tetramers link separated DNA response elements by DNA looping. Oncogene 16 2 (1998) 283-292
51. McKinney K., Mattia M., Gottifredi V., and Prives C. p53 linear diffusion along DNA requires its C terminus. Mol Cell 16 3 (2004) 413-424
52. Espinosa J.M., and Emerson B.M. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 8 1 (2001) 57-69
53. McKinney K., and Prives C. Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein. Mol Cell Biol 22 19 (2002) 6797-6808
54. Bourdon J.C. p53 family isoforms. Curr Pharm Biotechnol 8 6 (2007) 332-336
55. Moll U.M., and Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res 2 7 (2004) 371-386
56. Wang Y., Schwedes J.F., Parks D., Mann K., and Tegtmeyer P. Interaction of p53 with its consensus DNA-binding site. Mol Cell Biol 15 4 (1995) 2157-2165